The KUNO-Kids cohort included cross-sectional data from 2,044 children and longitudinal follow-up for 583 children born between 2015 and 2020. The study team reported vaccination coverage at three prespecified time-points: 6 months, 2 years, and 4 years. At the 2-year follow-up, coverage for each individually recommended vaccine fell short of the 90-95% targets recommended by the German Standing Committee on Vaccination (STIKO) and the World Health Organization. That shortfall persisted across vaccines; the cohort did not meet national benchmark levels for the 24-month age group. Reporting was limited to the abstract; the authors did not present detailed subgroup breakdowns or the statistical comparisons in the abstract text.
Vaccines requiring multiple doses in the first year had lower uptake. The investigators observed coverage for the hexavalent vaccine in the range of 71–76%. By contrast, vaccines initiated around 12 months and requiring fewer doses, such as MMR, reached higher coverage (86–87%). Short sentences clarify the pattern. Complex schedules in infancy—multiple visits and doses—correlated with lower adherence in this cohort, the authors noted. The abstract did not report exact dose timing, administration intervals, or reasons for missed doses, so further methodological detail would require consulting the full text.
Coverage increased for all recommended vaccines between the 2- and 4-year follow-ups. The cohort showed measurable catch-up prior to school entry. When the study team examined children who were incompletely vaccinated at age 2, they found that catch-up by age 4 occurred more frequently for MMR than for the hexavalent series. This suggests differential recovery depending on vaccine schedule and perhaps on parental or provider prioritization. The abstract did not provide absolute numbers for catch-up events nor the exact proportion of children who remained incomplete at 4 years for each vaccine; only relative trends and summary percentages were given.
Completion of the entire recommended primary immunization schedule was suboptimal early on. The study team reported that only about 50–55% of children had completed the full schedule at the 6-month and 2-year assessments. By the 4-year follow-up, completion proportions rose to a range between 59% and 76%. Some improvement occurred between the toddler and preschool years. Short, direct observation: many children received catch-up vaccinations before school entry but not all. The authors linked lower early completion to the complexity of the infancy schedule. The abstract did not specify which vaccine combinations accounted for the lower bound of the 59–76% range nor the denominators behind those percentages.
The investigators recommended interventions targeted at the first year of life. They mentioned vaccination reminder systems and health education initiatives as potential strategies to improve adherence. The study team observed that schedule complexity in the first year of life may influence adherence and that focused measures for this age group could bolster uptake. The abstract did not detail the operational design of proposed reminder systems, nor did it provide effect-size estimates for any intervention; these elements are not reported in the abstract.
Limitations reported in the abstract include reliance on KUNO-Kids cohort data (cross-sectional and longitudinal subsets) and the absence of national representativeness claims in the abstract text. The authors used the cohort to capture individual vaccination trajectories and catch-up dynamics—information the routine cross-sectional surveillance systems cannot provide—but the abstract did not present granular methodology such as inclusion criteria, adjustments for loss to follow-up, or statistical testing details. Unanswered clinical questions documented in the abstract include precise drivers of missed early doses, socioeconomic or regional disparities in coverage, and the projected impact of specific reminder or educational interventions. Readers should consult the full article for comprehensive methods, subgroup analyses, and the numerical breakdown underpinning the reported percentage ranges.
Ethical or competing-interest statements were included: the authors declared no known competing financial interests or personal relationships that could have influenced the study, as noted in the abstract.